Results 31 to 40 of about 284,773 (249)

Doubling the Dose of Bevacizumab Beyond Progression in Metastatic Colorectal Cancer–the Experience of a Tertiary Cancer Center

Frontiers in Pharmacology, 2021
Background: Colorectal cancer (CRC) is the third most common cancer in Europe, with an annual increase in incidence ranging between 0.4 and 3.6% in various countries.
Călin Căinap, Călin Căinap, Ovidiu-Vasile Bochiş, Cătălin Vlad, Cătălin Vlad, Raluca Popita, Raluca Popita, Patriciu Achimaş-Cadariu, Patriciu Achimaş-Cadariu, Andrei Havasi, Andreea Vidrean, Alexandra Dranca, Andra Piciu, Andra Piciu, Anne-Marie Constantin, Tiberiu Tat, Tiberiu Tat, Maniu Dana, Ovidiu Crişan, Cosmin Vasile Cioban, Ovidiu Bălăcescu, Ovidiu Coza, Ovidiu Coza, Loredana Bălăcescu, Monica Mihaela Marta, Madalina Bota, Simona Căinap   +26 more
doaj   +1 more source

The effect of glutamine intake on complications of colorectal and colon cancer treatment: A systematic review

Journal of Research in Medical Sciences, 2015
Background: Improvement in complications of antitumor agents and surgery is important to enhance life quality and survival among patients with colon and colorectal cancer.
Nahid Ramezani Jolfaie, Safiye Mirzaie, Reza Ghiasvand, Gholamreza Askari, Maryam Miraghajani   +4 more
doaj   +1 more source

Recent advances in minimally invasive colorectal cancer surgery [PDF]

, 2002
Laparoscopy has improved surgical treatment of various diseases due to its limited surgical trauma and has developed as an interesting therapeutic alternative for the resection of colorectal cancer.
Wichmann, Mathias W., Rau, H. G., Schildberg, Friedrich Wilhelm, Angele, M. K., Meyer, G., H.G. Rau, F.-W. Schildberg, G. Meyer, M.W. Wichmann, M.K. Angele   +9 more
core   +1 more source

Quality of Life and Predictors among Gastrointestinal Cancer Survivors in Iran

Iranian Journal of Nursing and Midwifery Research
Background: Quality of life (QoL) is an important indicator for evaluating treatment outcomes among cancer patients. Therefore, this study aimed to assess QoL and associated factors among Iranian gastric and colorectal cancer survivors.
Musab Ghaderi, Afzal Shamsi, Arman Azadi, Azad Rahmani   +3 more
doaj   +1 more source

The frequency of NRAS mutation in stool samples of Iranian colorectal cancers compared to Finnish patients

Journal of Research in Medical Sciences
Background: Stools from colorectal cancer patients are noninvasive samples that could be used to compare the frequency of hotspot mutations between two different ethnic cohorts.
Farideh Saberi, Omar Youssef, Arto Kokkola, Mahsa Khodadoostan, Pauli Puolakkainen, Rasoul Salehi, Sakari Knuutila   +6 more
doaj   +1 more source

Bevacizumab plus Irinotecan-Based Regimens in the Treatment of Metastatic Colorectal Cancer [PDF]

, 2010
Objectives: Bevacizumab is a monoclonal antibody that directly inhibits vascular endothelial growth factor, a key regulator of angiogenesis. Bevacizumab significantly improves progression-free and/or overall survival in metastatic colorectal cancer in ...
Volker Heinemann, Paulo M. Hoff, Heinemann, Volker, Hoff, Paulo M.   +3 more
core   +1 more source

Mapping the colorectal tumor microbiota

Gut Microbes, 2021
The gut microbiome in patients with colorectal cancer (CRC) is different than that of healthy controls. Previous studies have profiled the CRC tumor microbiome using a single biopsy.
CL Murphy, M Barrett, P Pellanda, S Killeen, M McCourt, E Andrews, M O’ Riordain, F Shanahan, Pw O’Toole   +8 more
doaj   +1 more source

Refocusing the Use of Psychiatric Drugs for Treatment of Gastrointestinal Cancers

Frontiers in Oncology, 2020
Gastrointestinal cancers (GICs) are the most common human tumors worldwide. Treatments have limited effects, and increasing global cancer burden makes it necessary to investigate alternative strategies such as drug repurposing. Interestingly, it has been
Mariana Avendaño-Félix, Maribel Aguilar-Medina, Mercedes Bermudez, Erik Lizárraga-Verdugo, César López-Camarillo, Rosalío Ramos-Payán   +5 more
doaj   +1 more source

Impact of Radiation Therapy on Physical and Psychosocial Health of Adolescents and Young Adults: A Joint Report From the Children's Oncology Group AYA and Radiation Oncology Committees

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Rates of cancer among adolescents and young adults (AYA), age 15–39 years, are increasing. Consequently, radiation oncologists are treating more AYAs who have diagnoses spanning both pediatric and adult practices. Compared to pediatric and older adult patients, AYAs face a unique set of challenges.
Hesham Elhalawani, Rachel K. Peterson, Avani D. Rao, Laurie J. McKenzie, Ahmed Magdy Elmotayam, Leslie Chang, Michael Roth, Susan L. McGovern   +7 more
wiley   +1 more source

Does ursodeoxycholic acid change the proliferation of the colorectal mucosa? A randomized, placebo-controlled study [PDF]

, 2003
Background: In animal models ursodeoxycholic acid (UDCA) showed a chemoprotective effect against colon cancer. To explain this, a reduced proliferation of the colorectal mucosal proliferation was suggested.
Burkhard Göke, Marsteller, I., Paumgartner, Gustav, Göke, B., Ochsenkühn, Thomas, Thomas Ochsenkühn, Hay, U., Igor Marsteller, Sackmann, M., Michael Sackmann, Joachim Diebold, Diebold, J., Ulrich Hay, Gustav Paumgartner   +13 more
core   +1 more source